SC 13G Filing

Company

Tempest Therapeutics, Inc.

Filed

March 31, 2017

Accession Number

0000935836-17-000181

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →